Updated breast cancer costs for women by disease stage and phase of care using population-based databases
Mittmann N, Seung SJ, Ante Z, Liu N, Yong JH, Yusuf A, Chiarelli AM, Earle CC. Health Rep. 2024; 35(11):3-11.
Publications
Evaluating real world health system resource utilization and costs for a risk-based breast cancer screening approach in the Canadian PERSPECTIVE Integration and Implementation project
Seung SJ, Mittmann N, Ante Z, Liu N, Blackmore KM, Richard ES, Wong A, Walker MJ, Earle CC, Simard J, Chiarelli AM. Cancers (Basel). 2024; 16(18):3189.
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data
Hernando-Calvo A, Nguyen P, Bedard PL, Chan KKW, Saleh RR, Weymann D, Yu C, Amir E, Regier DA, Gyawali B, Kain D, Wilson B, Earle CC, Mittmann N, Razak ARA, Isaranuwatchai W, Sabatini P, Spreafico A, Stockley TL, Pugh TJ, Williams C, Siu LL, Hanna TP. EClinicalMedicine. 2024; 69:102443. Epub 2024 Feb 12.
Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective
Seung SJ, Saherawala H, Nguyen L, Gatley JM, Liu N, Kebabdjian M, Earle C, Klotz L, Mittmann N. Can Urol Assoc J. 2023; 17(8):280-4. Epub 2023 May 30.
Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Eskander A. CMAJ Open. 2023; 11(3):E426-33. Epub 2023 May 9.
Early survival for patients newly diagnosed with cancer during COVID-19 in Ontario, Canada: a population-based cohort study
Fu R, Sutradhar R, Li Q, Kalraj P, Dare A, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Louie AV, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Gomez D, Look Hong NJ, Tinmouth J, Eskander A. Cancer Med. 2023; 12(10):11849-59. Epub 2023 Mar 31.
Cost-effectiveness of second-line ipilimumab for metastatic melanoma: a real-world population-based cohort study of resource utilization
Lu B, Dai WF, Croxford R, Isaranuwatchai W, Beca J, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Cancer Med. 2023; 12(10):11451-61. Epub 2023 Mar 31.
Impact of frailty on healthcare resource utilization and costs of care in myelodysplastic syndromes
Mozessohn L, Li Q, Liu N, Leber B, Khalaf D, Sabloff M, Christou G, Yee K, Chodirker L, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Liu Y, Earle CC, Cheung MC, Mittmann N, Buckstein R. JCO Oncol Pract. 2023; 19(4):e559-69. Epub 2023 Feb 10.
Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in Canada
Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, Coburn N, Hallet J, Dare A, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Finelli A, Louie AV, Look Hong NJ, Witterick IJ, Mahar A, Urbach DR, McIsaac DI, Enepekides D, Tinmouth J, Eskander A. JAMA Netw Open. 2023; 6(1):e2250394. Epub 2023 Jan 10.
The effect of specialized palliative care on end-of-life care intensity in AYAs with cancer
Jewitt N, Rapoport A, Gupta A, Srikanthan A, Sutradhar R, Luo J, Widger K, Wolfe J, Earle CC, Gupta S, Kassam A. J Pain Symptom Manage. 2023; 2023; 65(3):222-32. Epub 2022 Nov 21.